199 related articles for article (PubMed ID: 35975496)
1. Correlations of Leukotriene B4 and 25-Hydroxyvitamin D3 Levels with Disease Severity in Children with Henoch-Schonlein Purpura.
Zhu L; Zhang C; Xiang R; Luo Y
Clin Lab; 2022 Aug; 68(8):. PubMed ID: 35975496
[TBL] [Abstract][Full Text] [Related]
2. [Changes in 25-hydroxyvitamin D3 level in children with Henoch-Schönlein purpura].
Zhang YD; Dong QW; Li RM; Ji CY; Chu YT; Ma L; Zhang Y
Zhongguo Dang Dai Er Ke Za Zhi; 2017 Mar; 19(3):292-295. PubMed ID: 28302199
[TBL] [Abstract][Full Text] [Related]
3. [Clinical Significance of Serum Midkine in Children with Henoch-Schonlein Purpura].
Li MM; Liu N; Zhagn M; Xue HR
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Feb; 25(1):181-185. PubMed ID: 28245398
[TBL] [Abstract][Full Text] [Related]
4. Changes of Peripheral Blood Lymphocyte Subsets and Immune Function in Children with Henoch-Schonlein Purpura Nephritis.
Su Q; Jiang L; Chai J; Dou Z; Rong Z; Zhao X; Yu B; Wang Y; Wang X
Iran J Immunol; 2021 Sep; 18(3):259-267. PubMed ID: 34596591
[TBL] [Abstract][Full Text] [Related]
5. [Clinical significance of serum levels of IGF-1 and IGFBP-3 in children with Henoch-Schonlein purpura or Henoch-Schonlein purpura nephritis].
Ru L; Abudouhaer A; Guo YF
Zhongguo Dang Dai Er Ke Za Zhi; 2013 Nov; 15(11):1009-13. PubMed ID: 24229600
[TBL] [Abstract][Full Text] [Related]
6. [Serum levels of IL-5 and LTB4 in children with Henoch-Schonlein purpura].
Liao PY; Wu SH
Zhongguo Dang Dai Er Ke Za Zhi; 2006 Jun; 8(3):198-200. PubMed ID: 16787590
[TBL] [Abstract][Full Text] [Related]
7. Proteome analysis reveals novel serum biomarkers for Henoch-Schönlein purpura in Chinese children.
Liu L; Liu H; Zhu K; Zhang L; Yin X; Han L; Wang M; Gao S; Xiao X; Yang J; Huang C; Huang Y
J Proteomics; 2023 Mar; 276():104841. PubMed ID: 36796721
[TBL] [Abstract][Full Text] [Related]
8. Increased CD8+ T cells in patients with Henoch-Schonlein purpura nephritis exhibit suppressive immune activity.
Fengyong Z; Zhixiang F; Jiajia P; Qin L; Min Q; Guoliang W; Ziyan Z
Immunol Lett; 2022 Oct; 250():23-28. PubMed ID: 36174770
[TBL] [Abstract][Full Text] [Related]
9. Characteristics of immune function in the acute phase of Henoch-Schönlein purpura.
Ding Y; Zhou Y; Li HR; Xiong YH; Yin W; Zhao L
Clin Rheumatol; 2021 Sep; 40(9):3711-3716. PubMed ID: 33782751
[TBL] [Abstract][Full Text] [Related]
10. Pentraxin 3 as a novel early biomarker for the prediction of Henoch-Schönlein purpura nephritis in children.
Ge W; Wang HL; Sun RP
Eur J Pediatr; 2014 Feb; 173(2):213-8. PubMed ID: 23963627
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance of the serum biomarker index detection in children with Henoch-Schonlein purpura.
Purevdorj N; Mu Y; Gu Y; Zheng F; Wang R; Yu J; Sun X
Clin Biochem; 2018 Feb; 52():167-170. PubMed ID: 29129626
[TBL] [Abstract][Full Text] [Related]
12. Comparison of clinical, pathological and long-term renal outcomes of children with Henoch-Schonlein purpura nephritis and IgA nephropathy.
Torun Bayram M; Heybeli C; Yıldız G; Soylu A; Celik A; Sarioglu S; Kavukçu S
Int Urol Nephrol; 2022 Aug; 54(8):1925-1932. PubMed ID: 34846620
[TBL] [Abstract][Full Text] [Related]
13. [Relationship between leukotrienes and clinical, pathological features of Henoch-Schoenlein purpura nephritis in children].
Chen XY; Yi ZW; He QN
Zhonghua Er Ke Za Zhi; 2008 Apr; 46(4):272-5. PubMed ID: 19099729
[TBL] [Abstract][Full Text] [Related]
14. [Association of serum vitamin D level with severity and treatment in children with Henoch-Schönlein purpura].
Fan L; Liu H; Wang YC; Chen L; Zhou JJ; Cui YX
Zhongguo Dang Dai Er Ke Za Zhi; 2017 Jul; 19(7):796-799. PubMed ID: 28697834
[TBL] [Abstract][Full Text] [Related]
15. Investigating the comparative effect of vitamin D level with the type of complications in Henoch Schönlein purpura and Kawasaki disease.
Yeganeh MH; Sinaei R; Rouhi M; Shiari R; Parvaneh VJ; Rahmani K; Sheikhbahaei E
Reumatol Clin (Engl Ed); 2024 Apr; 20(4):199-203. PubMed ID: 38644031
[TBL] [Abstract][Full Text] [Related]
16. Analysis of children with Henoch-Schonlein purpura secondary to infection.
Liu C; Luo L; Fu M; Li Z; Liu J
Clin Rheumatol; 2022 Mar; 41(3):803-810. PubMed ID: 34993728
[TBL] [Abstract][Full Text] [Related]
17. Risk factors associated with renal crescentic formation in pediatric Henoch-Schönlein purpura nephritis: a retrospective cohort study.
Song YR; Guo WL; Sheng M; Lin Q; Zhu XM; Li XZ
BMC Pediatr; 2020 Nov; 20(1):501. PubMed ID: 33131493
[TBL] [Abstract][Full Text] [Related]
18. Circulating midkine in children with Henoch-Schönlein purpura: Clinical implications.
Su Z; Lv X; Liu Y; Zhang J; Guan J; Gai Z
Int Immunopharmacol; 2016 Oct; 39():246-250. PubMed ID: 27497193
[TBL] [Abstract][Full Text] [Related]
19. Modified Sipjeondaebo-tang (JAROTANG) for Henoch-Schonlein purpura nephritis (HSPN): Two case reports.
Cho S; Jang S; Ryu SS; Park S
Explore (NY); 2023; 19(3):439-444. PubMed ID: 36280432
[TBL] [Abstract][Full Text] [Related]
20. The relationship between red cell distribution width and the risk of Henoch-Schönlein purpura nephritis.
Zhu X; Zhang M; Lan F; Wei H; He Q; Li S; Qin X
Br J Biomed Sci; 2018 Jan; 75(1):30-35. PubMed ID: 28990845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
